Significant Increase in Adjusted EPS
Adjusted earnings per share (EPS) for Q4 were $0.99, a 77% increase compared to the previous year. For the full year 2024, adjusted EPS was $2.85, representing a 61% increase from the prior year.
Strong Organic Sales Growth
Q4 organic sales growth was 27%, with over 20% growth in both the Americas and APAC, and over 30% in EMEA. For the full year 2024, organic sales grew by 18% across all regions.
Robust Free Cash Flow
Adjusted free cash flow was $362 million in Q4 and over $1.1 billion for the year, with a conversion rate of 103%.
Strong Balance Sheet and Capital Deployment
Net leverage reduced to 1x by year-end, with $600 million of share repurchases in 2024 and a 50% increase in dividends. R&D investment increased by $50 million.
Positive Market Outlook for 2025
Projected adjusted EPS for 2025 is between $3.5 and $3.6, with sales estimated at approximately $9.2 billion, despite FX headwinds.
Record Operating Margin Expansion
Adjusted operating margin expanded by 380 basis points in Q4 to 21.5%, and by 410 basis points for the full year to 19.4%.